Post-Inspection At the conclusion of the inspection, the investigator will request a closing meeting with management. If conditions that the investigator believes to be CGMP deviations have been observed, a form FDA 483 “Notice of Inspectional Observations” will be issued. If any of the deviations have been corrected and the corrections shown to the investigator [...]